Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, Zgonc V, Blancato J, Krawczyk E, Gallicano GI, Girgis M, Cheema A, Iżycka-Świeszewska E, Cavalli LR, Pack SD, Kitlinska J. Lu C, et al. Among authors: cavalli lr. Nat Commun. 2022 Apr 28;13(1):2323. doi: 10.1038/s41467-022-29898-x. Nat Commun. 2022. PMID: 35484119 Free PMC article.
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.
Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB. Hong SH, et al. Among authors: cavalli lr. J Vis Exp. 2016 Dec 9;(118):54532. doi: 10.3791/54532. J Vis Exp. 2016. PMID: 28060251 Free PMC article.
Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, Zgonc V, Blancato J, Krawczyk E, Gallicano GI, Girgis M, Cheema A, Iżycka-Świeszewska E, Cavalli LR, Pack SD, Kitlinska J. Lu C, et al. Among authors: cavalli lr. Nat Commun. 2022 May 12;13(1):2729. doi: 10.1038/s41467-022-30473-7. Nat Commun. 2022. PMID: 35550518 Free PMC article. No abstract available.
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.
Stires H, Heckler MM, Fu X, Li Z, Grasso CS, Quist MJ, Lewis JA, Klimach U, Zwart A, Mahajan A, Győrffy B, Cavalli LR, Riggins RB. Stires H, et al. Among authors: cavalli lr. Mol Cell Endocrinol. 2018 Aug 15;471:105-117. doi: 10.1016/j.mce.2017.09.024. Epub 2017 Sep 19. Mol Cell Endocrinol. 2018. PMID: 28935545 Free PMC article.
Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.
Sugita BM, Pereira SR, de Almeida RC, Gill M, Mahajan A, Duttargi A, Kirolikar S, Fadda P, de Lima RS, Urban CA, Makambi K, Madhavan S, Boca SM, Gusev Y, Cavalli IJ, Ribeiro EMSF, Cavalli LR. Sugita BM, et al. Among authors: cavalli ij, cavalli lr. Oncotarget. 2019 Oct 22;10(58):6184-6203. doi: 10.18632/oncotarget.27250. eCollection 2019 Oct 22. Oncotarget. 2019. PMID: 31692930 Free PMC article.
93 results